small molecule

PHENYLEPHRINE HYDROCHLORIDE

PHENYLEPHRINE HYDROCHLORIDE

Loss of exclusivityNovember 2033latest FDA-listed patent expiry
CompanyPARAGON BIOTECK INC

Drug detail

Brand namePHENYLEPHRINE HYDROCHLORIDE
Active ingredientPHENYLEPHRINE HYDROCHLORIDE
Strength2.5%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMarch 2013
Marketing statusRX

Listed patents

PatentExpiresType
8859623November 2033use U-1594

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

PHENYLEPHRINE HYDROCHLORIDE patent cliff — loss of exclusivity November 2033 | CliffBio